Clinical

The date by which a follow-up action related to a patient sensitivity record is required, such as allergy confirmation testing, specialist referral, or medication reconciliation review. Used in clinical workflow systems to trigger care coordination tasks associated with documented substance sensitivities.

The length of time a patient experienced symptoms or a clinical reaction associated with a documented sensitivity or adverse substance event. Used in clinical data systems to characterize the severity and persistence of allergic reactions, supporting treatment planning and pharmacovigilance reporting.

The electronic mail address associated with a patient, clinician, or contact linked to a sensitivity record, used for communicating allergy-related notifications or follow-up correspondence. Captured in clinical data systems to support patient outreach and care coordination around documented substance sensitivities.

A flag identifying whether a patient's documented sensitivity or allergic reaction requires emergency-level clinical response, such as anaphylaxis requiring epinephrine. Used in EHR and clinical decision support systems to trigger urgent alerts and prioritize medication safety screening at the point of care.

The date on which a documented patient sensitivity or adverse reaction period was considered resolved, expired, or no longer clinically active. Used in EHR and clinical data systems to define the active window of an allergy record and support accurate medication safety screening over time.

The specific time at which a patient's sensitivity reaction or the clinical monitoring period associated with an adverse substance event was recorded as concluded. Used in clinical data systems to precisely document the resolution of an allergic event for longitudinal reaction duration analysis.

The identifier of the clinician, pharmacist, or data entry user who documented a patient sensitivity or allergy record in the clinical system. Used in EHR audit trails to attribute allergy documentation to a responsible party, supporting accountability, data quality review, and regulatory compliance.

The patient's self-reported or recorded ethnicity associated with a sensitivity record, used to support population-level analysis of adverse reaction prevalence across demographic groups. Captured in clinical data systems to enable health equity research and pharmacogenomic studies related to substance sensitivities.

The date after which a documented patient sensitivity record is considered outdated or requiring clinical revalidation. Used in EHR and allergy management systems to prompt review of allergy histories, ensuring that active sensitivity alerts reflect current and clinically verified patient information.

A reference identifier assigned to a patient sensitivity or allergy record by an external system, such as a referring facility, HIE, or pharmacy network. Used to link and reconcile sensitivity records across disparate clinical data systems, ensuring continuity of allergy information during care transitions and data exchange.

The facsimile number associated with a recorded patient allergy or substance sensitivity record, used to transmit clinical sensitivity documentation to treating providers, specialists, or pharmacies requiring notification of patient reactivity history.

The service charge or cost associated with allergy or sensitivity testing procedures, such as skin prick tests or serum IgE assays, recorded in the clinical billing system to support claims adjudication and patient cost documentation.

The given name of the individual, clinician, or reporter associated with a documented allergy or substance sensitivity record, used to identify the patient or contact linked to the sensitivity entry in the clinical record.

A binary indicator applied to a patient allergy or substance sensitivity record that signals active status, critical severity, or a condition requiring clinical attention, used to trigger alerts in medication ordering, clinical decision support, and care workflows.

The recorded occurrence rate or recurrence pattern of reactions associated with a documented patient allergy or substance sensitivity, used in clinical assessments to evaluate exposure history and inform treatment or avoidance planning decisions.

The complete display name of the allergen, substance, or reactant documented in a patient sensitivity record, combining all name components to provide a full human-readable identifier used in clinical documentation and patient-facing allergy summaries.

The biological sex or gender identity of the patient associated with an allergy or substance sensitivity record, captured to support demographic analysis, population health reporting, and epidemiological studies of sensitivity prevalence by sex.

The blood glucose measurement recorded in the context of a patient sensitivity or allergic reaction event, used to assess metabolic response during anaphylaxis, corticosteroid treatment for allergic conditions, or sensitivity-related clinical encounters.

The hemoglobin laboratory value recorded in association with a patient allergy or sensitivity encounter, used to assess hematologic impact of chronic allergic conditions, medication sensitivities, or adverse drug reactions affecting red blood cell production.

The narrative clinical description of a patient's current allergic or sensitivity-related symptoms and circumstances, documented at the time of encounter to capture onset, duration, triggers, and progression of the sensitivity reaction being evaluated.